Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer
ConclusionsMost SMNs were unrelated to treatment, and the 15-year incidence was similar to that of cancer in the SEER control group —findings that should be reassuring to patients. Further risk reduction is expected from prophylactic gynecologic surgery. Continued investigations into genetic links with melanoma are warranted.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Breast Carcinoma | Breast Conservation Surgery | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Epidemiology | Genetics | Hormonal Therapy | Hormones | Melanoma | Skin Cancer | Study | Women